Siponimod Chips Away at Progressive MS.
Cell
; 179(7): 1440, 2019 Dec 12.
Article
em En
| MEDLINE
| ID: mdl-31951523
Progressive multiple sclerosis (PMS) causes slow accumulation of neurologic disability and has been refractory to treatment with the immunomodulatory medications that effectively control relapsing MS. Siponimod modestly slowed the rate of disability progression among PMS patients who had inflammatory disease activity, evidenced by new or gadolinium-enhancing MRI lesions. To view this Bench to Bedside, open or download the PDF.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Azetidinas
/
Compostos de Benzil
/
Ensaios Clínicos como Assunto
/
Esclerose Múltipla
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Cell
Ano de publicação:
2019
Tipo de documento:
Article